Of note, tumor cells rely on glucose metabolism to obtain a large amount of energy, leading to overexpression of GLUT-1 in a wide range of tumors, including hepatic, pancreatic, breast, esophageal, brain, renal, lung, cutaneous, colorectal, endometrial, ovarian, and cervical cancers (76). Here, SLC2A1 is linked to neoplasm.